Dolphin
Senior Member (Voting Rights)
Free full text:
https://s3.amazonaws.com/academia.e...G_Canada_full_dergi20191028-29026-1rwjffk.pdf
https://s3.amazonaws.com/academia.e...G_Canada_full_dergi20191028-29026-1rwjffk.pdf
CEOG Clinical and Experimental
Obstetrics & Gynecology
7847050 Canada Inc.
www.irog.net
Clin. Exp. Obstet. Gynecol. - ISSN: 0390-6663
XLVI, n. 5, 2019
doi: 10.12891/ceog5179.2019
The increased cellular permeability syndrome manifesting as severe idiopathic type urinary incontinence
J.H. Check1,2, D. Check2
1Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ
2Cooper Institute for Reproductive Hormonal Disorders, P.C. Mt. Laurel, NJ (USA)
Summary
Purpose: To evaluate the efficacy of treatment with dextroamphetamine sulfate for severe idiopathic urgency urinary incontinence refractory to treatment with the selective beta 3 adrenergic agonist, mirabegron.
Materials and Methods: Dextroamphetamine sulfate extended release capsule was started at 9.4 mg and increased to 15.7 mg in a woman with two years of severe urgency urinary incontinence.
Results: The urgency urinary incontinence completely resolved, as did the fibromyalgia, headaches, and chronic fatigue syndrome. The symptoms have remained eradicated for over one year while treatment continues.
Conclusions: Idiopathic urgency urinary incontinence (neurogenic bladder) has been found to be another manifestation of the increased cellular permeability syndrome. Similar to the other chronic disorder associated with the increased cellular permeability syndrome, idiopathic urgency urinary incontinence responds well to dextroamphetamine sulfate treatment despite failure to respond to standard therapy.
Key words: Idiopathic urgency urinary incontinence; Neurogenic bladder; Dextroamphetamine sulfate; Increased cellular permeability
syndrome; Dopamine.
Last edited: